GlassScriptPhysician profile
Kristina E Leedham
NPI 1992045165
$1,533.32
in general payments reported to CMS, 2019-2025
23 companies · $17.67 in 2025
The $17.67 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $762 · 2022: $649 · 2023: $105 · 2025: $17.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $224.65 | 2021-2023 | Erleada |
| Astellas Pharma US INC | $169.68 | 2021-2022 | |
| Pfizer INC. | $168.41 | 2021-2022 | |
| Antares Pharma, INC. | $141.95 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $137.33 | 2021-2023 | Aveed, Xiaflex |
| Urovant Sciences INC | $122.93 | 2021-2022 | |
| 180 Medical, INC. | $78.54 | 2021-2025 | Gentlecath |
| Rochester Medical Corporation | $54.06 | 2021-2022 | |
| Amgen INC. | $51.41 | 2022 | |
| Genzyme Corporation | $44.93 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $42.24 | 2021-2022 | |
| Dentsply Ih INC. | $40.11 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $37.71 | 2021 | |
| Sumitomo Pharma America, INC. | $35.12 | 2023 | Gemtesa |
| Palette Life Sciences, INC. | $25.00 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.45 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $24.22 | 2021 | |
| Abbvie INC. | $22.92 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $22.66 | 2022 | |
| Convatec INC. | $19.60 | 2021 | |
| Travere Therapeutics, INC. | $18.19 | 2021 | |
| Myriad Genetic Laboratories, INC. | $14.75 | 2021 | |
| Hollister Incorporated | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Leedham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.